OptimizeRx Corp 2023 Sustainability Report
The report describes a formal stakeholder materiality assessment that identified cybersecurity and data privacy as the most critical risks and DEI&B and community engagement as leading opportunities. It reports a preliminary Scope 1 and 2 review for US operations, including 5.82 metric tons of Scope 2 emissions and no Scope 1 emissions to report. The company also highlights its 2023 DEI&B Committee, Parity Pledge, and expanded inclusion initiatives. It states that no workplace fatalities or workers' compensation claims from workplace injuries were reported in the last three years.
Company: OptimizeRx Corp
Sector: Technology & telecommunications
Country: United States
Year: 2023
Type: Sustainability Report
Pages: 31
OptimizeRx Corp
The report describes a formal stakeholder materiality assessment that identified cybersecurity and data privacy as the most critical risks and DEI&B and community engagement as leading opportunities. It reports a preliminary Scope 1 and 2 review for US operations, including 5.82 metric tons of Scope 2 emissions and no Scope 1 emissions to report. The company also highlights its 2023 DEI&B Committee, Parity Pledge, and expanded inclusion initiatives. It states that no workplace fatalities or workers' compensation claims from workplace injuries were reported in the last three years.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Published
Mar 1, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Women on Board
Women in Management
Workplace Fatalities
Employees